Hormonal Regulation and Therapeutic Interventions in Animal Reproduction

INTRODUCTION

The endocrine system controls the intricate process of reproduction in animals. The estrous cycle, ovulation, conception, pregnancy, and parturition are all regulated by hormones. By understanding how these hormones function, farmers and veterinarians can now control reproductive cycles to increase yield and better control breeding. In both people and wild animals, reproductive success is the ability of an organism to create offspring that will procreate in the next generation, thus ensuring a person's genetic line. In humans and domesticated animals, measuring reproductive success is very commonplace; in wild species, however, this is not always the case. Despite these difficulties and the fact that many biotic (such as parental, nutritional status, etc.) and natural abiotic (such as temperature, photoperiod, etc.) factors affect reproductive success in any given organism, there is strong evidence that environmental chemicals reduce reproductive success in all major vertebrate taxa and in many invertebrate species (Marlatt et al., 2022).

To improve fertility, control cycles, trigger estrus, treat infertility, and aid artificial breeding methods, hormone therapies are frequently utilized in animal reproduction. Reproductive efficiency is enhanced by these treatments, particularly in commercial animal production, as the success of breeding is highly dependent on precise timing. Hormonal therapy (HT) has potential therapeutic applications in the management of mental disorders. Menopausal symptoms and cognitive dysfunction have been the main focus of studies on hormonal treatment; psychiatric disorders have received less attention, even though many women cite improved depressive symptomatology as one of the clinical justifications for continuing hormonal therapies (Ancelin et al., 2017).

ROLE OF ENDOCRINE SYSTEM IN ANIMAL REPRODUCTION

Growth and development, metabolism, sexual function and reproduction, sleep, and mood are all critical physical activities that are regulated and coordinated by the endocrine system, which is made up of glands and tissues that create and secrete hormones. Endocrine glands, including the thyroid, parathyroid, and adrenal glands, as well as tissues like bone and fat (adipose tissue), which have secondary endocrine functions and secrete a variety of hormones, make up the remarkably complex endocrine system (Chapin et al., 1996). An important class of organs that can undergo chemically induced alterations in both short-term and long-term preclinical toxicity studies is the endocrine glands. Making the distinction between compound-induced effects and spontaneous or stress-related alterations is crucial. Although there are numerous examples of pharmaceuticals that have been linked to neoplastic or degenerative changes in laboratory animals' endocrine glands, the body of evidence pertaining to their pathogenesis and mode of action has shown that they are not relevant to humans. Chemicals can have a direct or indirect effect on the endocrine glands and their toxicity (Rosol et al., 2024).

GnRH

GnRH must be released pulsatilely into the hypothalamic-hypophyseal portal veins in order to trigger the secretion of gonadotropins. GnRH release is regulated by a complex neural network that includes peripherally produced signals as well as hypothalamic and extra-hypothalamic inputs (Table 1). Numerous studies have examined the central and peripheral signals that modulate GnRH secretion, and various stimulatory (such as kisspeptin, norepinephrine, and neuropeptide Y, estrogens) or inhibitory (such as endogenous opioids, interleukin-1, estrogens, progesterone, androgens) factors have been found in humans. Lastly, GnRH may control its release by means of an extremely brief feedback loop on neurons in the hypothalamus (Casati et al., 2023).

LH Hormone

The anterior pituitary secretes luteinizing hormone (LH), which functions in reproductive processes like female ovulation and male androgen production. An essential part of controlling the human reproductive cycle is the endocrine system. The two gonadotropin hormones, human chorionic gonadotropin (hCG) and follicle-stimulating hormone (FSH), as well as LH, are necessary for controlling sexual and reproductive processes. Because it affects the gonads (ovaries or testes) of both sexes, LH plays a crucial evolutionary role. It is essential for biological functions such the production of sex steroids in both sexes and the female reproductive process of ovulation (Oduwole et al., 2021).

ENHANCING FERTILITY AND PRODUCTIVITY

In dairy cattle, reproductive performance is being negatively impacted by improved genotypes for milk production. Even though fertility weightings have been incorporated into breeding values in many nations, it will take some time for herd owners to notice phenotypic changes as a result of these genetic modifications. More production may also have phenotypic effects that obscure the genetic tendency toward better reproduction. The application of hormone intervention is a quick fix for decreasing fertility in dairy herds. This research aims to examine the fundamental approaches utilized to enhance the reproductive capabilities of dairy cattle under various production methods (Ipsa et al., 2019).

To regulate the timing of the initial insemination, the following inseminations in non-pregnant cows, and the treatment of anestrous cows, a number of hormonal treatments have been developed. When a reproductive system is fully tuned, its efficiency is 100%. Enhancing current efficiency can be achieved by applying additional therapies that increase fertility after synchronization, or by improving the upfront synchronization mechanism (Chang et al., 2022).

MANAGING REPRODUCTIVE DISORDERS

Reproductive efficiency in cattle farming systems has a major impact on farm output, profitability, and sustainability. Either directly or indirectly, through management choices such as replacement and culling rates, the reproductive success of farm animals determines the efficiency of milk and or meat production. The foundation of optimal reproductive management is the use of precise techniques, which must also take human health, environmental effects, animal welfare, and costs into account. The majority of reproductive management techniques are prepared for use in commercial livestock farms once the approach that best suits each farm's objectives has been chosen. The prevention and treatment of reproductive disorders, nutritional management, reproductive aided techniques (primarily artificial insemination and estrous synchronization), and one or more biostimulating tools (such as the male effect) are examples of such strategies (Hashem & Gonzalez-Bulnes, 2021).

Biological factors may have an impact on the pharmacokinetics and pharmacodynamics of hormone-based reproductive medicines, which are the preferred approach for managing reproduction. The male effect is a method of sexual biostimulation that offers a way to avoid using a lot of hormones for reproductive control and to produce animal products free of hormone residues. However, the results of this method are limited by the sexual activity of both males and females, the ratio of males to females, the male's age, and his experience. The lack of nutrients' bioavailability and inadequate distribution of necessary nutrients can also have a negative effect on nutritional management strategies aimed at enhancing farm animals' reproductive function. Finally, concerns about the overuse of antibiotics and the emergence of antibiotic-resistant bacteria provide a challenge to the treatment of disorders linked to reproduction (Qaid & Abdoun, 2022).

SYNCHRONIZING BREEDING CYCLES

Synchronization of estrus is one of the sophisticated management techniques that could reduce both the costs and humanistic errors. It is most helpful in sheep, where it is challenging to detect heat in a timely manner since they show fewer outward signs of heat, and in big herds of cattle.

By setting the breeding time inside a limited predetermined window, it helps to schedule the parturition time within the most advantageous season, when the newborns may be raised in a suitable environment with plenty of food to increase their chances of survival. Farm animals may be predicted to be more fertile on the upper side since this strategy allows for timely animal breeding. Estrus synchronization increases the monetary rewards to the owner by increasing the animals' production efficiency (Pal & Dar, 2021).

Depending on the treatment plan, synchronization can reduce the breeding period from 21 days to less than 5 days rather than the usual 21 days. The production of a consistent group of calves for the animal farm's future replacement is yet another significant advantage of this method. Estrous synchronization's current and future aspects center on follicular development modification in conjunction with conventional techniques for regulating cycle duration. Cattle's estrus synchronization with follicular development modulation has advanced significantly through the combined use of GnRH with prostaglandin F_2α and progesterone based synchronization protocols (Pesendorfer et al., 2021).

CONTROL OF ESTROUS CYCLE

The brain, pituitary, and ovaries all have specific hormonal interactions that are necessary for the menstrual and estrous cycles. The ovarian hormones, progesterone and estradiol, supply one of the system's primary homeostatic hormonal loops by regulating the activity of the neural network that governs the release of gonadotropin-releasing hormone (GnRH). To produce discrete pulses of follicle-stimulating hormone and luteinizing hormone (LH) during the ovarian cycle, the GnRH neurons release GnRH episodically into the pituitary portal circulation. With one pulse produced hourly during the follicular/diestrous phase of the cycle and a slower rate of one pulse every three to four hours after ovulation during the estrous/luteal phase, this pattern of pulsatile secretion is remarkably consistent throughout mammals. All spontaneously ovulating mammals experience the preovulatoryGnRH/LH surge, which is caused by an abrupt and large outpouring of GnRH. This is the only other significant alteration that takes place during the cycle. In order to allow for proper follicular growth, the brain and pituitary produce a continuous pulsatile pattern of gonadotropin secretion that slows during estrous. At mid-cycle, this pattern of secretion surges to start ovulation (McQuillian et al., 2021).

In order to control the estrous cycle, hormones are frequently utilized. Hormonal control of estrus is primarily used to suppress estrous, induce luteolysis, induce ovulation of a mature follicle, produce cyclicity in anestrous animals, and superovulate cyclic animals. Different animals respond differently to these estrous cycle modifications. Furthermore, a lot of therapies aren't yet approved by the government; veterinarians who prescribe them should read the labels carefully and abide by all applicable rules and regulations (Herbison, 2020).

Estrous Detection and Timing

In dairy farms, poor reproductive performance is largely caused by low estrus detection efficiency, which costs the cow sector a lot of money. Breed, postpartum period, parity, milk output, health, diet, weather, stress, hormonal treatment, bull presence, housing, and herd size are some of the variables that can impact the intensity of estrus expression and the ability to identify it. The technique most frequently employed for detecting estrus is visual observation. The combination of artificial insemination and heat detection is made possible by the use of hormonal protocols for synchronizing estrus and ovulation (Palomares, 2021).

Successful fertility management and the foundation of a profitable milk production depend on effective estrus detection. The conditions for optical estrus identification are getting harder as a result of agricultural intensification, the ensuing expansion of dairy herds, and the farmers' growing workload. Poor conception rates, financial losses, and deteriorating fertility performance are all consequences of inadequate estrus detection. To assess an estrus sign's stability, only the indications with the highest score during an observation period were assessed. The evaluation did not include any of the previously mentioned score 1-estrus signals, for instance, if an animal displayed estrous behavior by mounting another cow (score 2). Whether or not the cow was in ov-estrus was also examined at the same time. Cows with scores of 2 or 3 for behavior also displayed grade 1 estrus symptoms in the same (Gaude et al., 2021).

ESTRUS SYNCHRONIZATION PROTOCOLS

Using prostaglandin to cause the corpus luteum (CL) to recede prior to the animal's natural luteolysis and using progesterone or, more frequently, synthetic progestins to temporarily inhibit ovarian activity are the two main methods for regulating the length of the estrous cycle. Gonadotropin-releasing hormone (GnRH) or an analog, either by itself or in conjunction with other hormones, is another method of establishing estrous synchronization. This promotes big follicles to ovulate. Some benefits of an estrous synchronization protocol include: uniform calf crop production, i.e., of a similar age group; artificial insemination and embryo transfer techniques to reduce time and labor detecting estrus; and a short calving interval that allows females (especially heifers) to conceive earlier (Arya et al., 2023).

Use of PGF2α, CIDRs, and Progesterone Devices

One of the Estrous Synchronization protocols, PGF2α, is a naturally occurring hormone that causes luteolysis, or corpus luteum regression, and reduces progesterone production, thereby bringing about a return to estrus. Because pre-pubertal heifers and anestrous cows lack luteal tissue, PGF2 alpha injections are ineffective in these animals. For instance, PGF2 alpha is only utilized in estrous-cycle cows to synchronize an ovulatory estrus. Additionally, animals that are not cycling may not start cycling after receiving a PGF2 alpha injection. Because of this, PGF2 is essential for determining the proportion of cycling heifers or cows before starting therapy with PGF2 alpha alone to synchronize this process. PGF2 alpha and progestin therapy are the most effective methods for synchronizing estrus in herds that contain both cyclic and non-cycling females. Because it induces abortion in pregnant nutritional heifers earlier than 100 days of gestation, PGF2 alpha is very effective. The PGF2 alpha-based protocol can be injected in two different ways: once and twice (Haile et al., 2023).

Controlled internal drug-releasing device

The United States has developed a controlled internal drug-releasing (CIDR) device for lactating dairy calves that uses an intravaginal insert impregnated with 1.38 grams of progesterone. The return to estrus of non-pregnant cows is improved when a CIDR is used between 14 and 21 days following AI. Additionally, the CIDR's integration into the AI protocol increased the pregnancy rates of ovulatory dairy and beef cows. In some herds, over 40% of the primiparous cows do not cycle by the 65-day mark, resulting in decreased conception rates and higher embryonic losses. In the United States, over 20% of the lactating dairy cows experience anovulation by that time. CIDR therapy for 7 days in anovulatory cows. Increased pregnancy rates were achieved by better detecting the estrus ovulation rate and incorporating a CIDR into a timed AI procedure that uses GnRH to induce ovulation (Knights & Singh-Knights, 2016).

Common methods for sterilizing previously used CIDR equipment, like autoclaving and disinfection, can potentially have an impact on the P4 content. P4 concentrations were found to be greater (p = 0.06) in anoestrus goats treated with a 14-day autoclaved CIDR than in goats treated with re-used, disinfected devices. Despite these findings, autoclaving previously used devices had no influence on anoestrus ewe fertility. Reused CIDRs on fertility have generally not been documented by many studies. Since the fertility of breeding males is also harmed during the anoestrus season, the reusing or autoclaving of precious used CIDRs does not appear to have an impact on fertility. However, instances in which this effect has been seen may be due to the season or the length of prior use. As a result, reproductive outcomes in females treated with re-used short-term CIDR devices may be influenced by the length of prior use and the treatment season (Nakafeero et al., 2024).

It has been demonstrated that sheep estrous is induced during the anestrous period by exogenous progesterone given using CIDR devices. Researchers found that using a CIDR for a 6 d synchronization period (as opposed to 3, 9, and 12 d) during the breeding season maximized net profit. In 2009, the US Food and Drug Administration authorized the use of CIDR sheep inserts to induce estrous in seasonally anestrous ewes.The overall fertility of CIDR-treated ewes during the anestrous time, however, has been lower than that of ewes during the regular breeding season. Consequently, this tool's cost-effectiveness has been subpar for commercial sheep breeders (Redden et al., 2023).

Progesterone devices

During follicular maturation, regulating the levels of circulating progesterone (P4) is a crucial component of synchronization protocols for cattle timed artificial insemination (TAI). Follicle growth following dominant follicle (DF) selection is mostly regulated by the pulse frequency of luteinizing hormone (LH) which is influenced by the levels of circulating steroid hormones, including P4 and estradiol (E2). More specifically, circulating P4 concentrations lower the frequency of the LH pulse, which slows the growth of the DF. In order to control follicular growth, grow a DF of appropriate size and E2 production, and ultimately have ovulatory capacity, it is necessary to manage circulating P4 during a synchronization protocol (Silva et al., 2022).

It is standard procedure in beef cattle synchronization programs to increase the control of circulating P4 concentrations by inserting an intravaginal P4 device at the start of the treatment. Since the 1970s, intravaginal P4 devices for cattle have been commercially available. They are commonly utilized in GnRH-based protocols and E2/P4-based procedures in conjunction with estradiol benzoate. A variety of P4 devices are currently on the market and can be used to manage the reproduction of beef cattle (Carvalho et al., 2023).

BENEFITS OF SYNCHRONIZING ESTRUS

Synchronization programs use artificial insemination (A.I.) or natural service (bulls) to breed a large percentage of the females in a specific group of heifers or cows in a short amount of time. The ability to coordinate livestock's ovulation and estrus timing has benefits. By using synchronization techniques, effort can be concentrated at parturition and the animal crop is uniform. In addition to being expensive and time-consuming, estrous synchronization technologies typically result in lower conception rates than natural services. Other benefits of systematic breeding operations include increased heat detection efficiency, increased pregnancy rates will result in fewer cows having different calving times, allowing for a more timely first service. Perhaps limit involuntary culling for reproductive purposes, focus work on reproductive management during certain times, cure ovarian cysts and quiet heat while also enhancing the herd's overall reproductive performance (Yizengaw, 2017).

It has many benefits such as producing more animals in estrus in a shorter amount of time, which improves the utilization of artificial insemination. Enables producers to coordinate breeding schedules to accommodate other necessary tasks efficiently. Eliminates or drastically cuts down on the time and effort needed for heat detection. It also significantly shortens the time required to inseminate the animals. Cutting down or doing away with the work involved in identifying estrus. Giving the manufacturer the freedom to plan the breeding and calving so that more cows can be artificially inseminated (Habeeb and Kutlzer, 2021).

SUPEROVULATION TECHNIQUES

Wisconsin, in the United States, was the first place where superovulation in sheep and cattle was documented. Basically, the goal was to induce numerous ovulations by administering gonadotropins several days ahead of the expected typical estrus. About five days later, or at the start of estrus, a human chorionic gonadotropin (hCG) injection was frequently administered to stimulate ovulation. Equine chorionic gonadotropin (eCG or PMSG) became the standard method, despite reports of investigations on the use of anterior pituitary preparations from sheep, horses, cattle, and pigs. According to Betteridge, in the early days of bovine embryo transfer, there was widespread agreement that eCG should be given to animals experiencing natural luteolysis at around Day 16 of the estrous cycle, which is when the luteal phase transitions to the follicular phase (Bo and Mapletoft, 2014).

Superovulation and Commercial Embryo Transfer

In the early 1970s, the commercial embryo transfer sector in North America started to take shape with the arrival of continental cattle breeds, which were then in short supply. Rapidly increasing their numbers was made possible by superovulation and embryo transfer. Even though eCGwas first utilized, extensive research led to practitioners' approaches to superovulation changing quite quickly. When there is a high demand for genetically superior donors, superovulation can increase the number of such animals, making it a crucial phase in the MOET program. A goat normally produces one to three eggs during each estrous cycle. However, with superovulation—which entails giving approximate dosages of the FSH hormone—it is feasible to obtain approximately 10–20 accessible oocytes with 13 transferable embryos. Artificially administering hormone therapy with gonadotropins, such as PMSG or FSH, to stimulate the growth of multiple follicles, which ultimately leads to ovulation, is the fundamental concept behind superovulation (Khan et al., 2022).

FSH-Based Protocols for Multiple Ovulation

In connection with an ovarian response, the efficacy of the FSH dosage was also examined. According to the researchers, ovarian responses were comparable when 145 and 215 mg of FSH were administered in seven doses over 3.5 days; however, when the dose was lowered to 80 mg using the same protocol, noticeably greater responses were seen. When administering FSH doses of 8.8 mg and 14.08 mg beginning 48 hours before CIDR removal, some scientists observed no discernible variation in the quantity of recovered and transferrable embryos (Gutierrez-Reinoso et al., 2022).

The ovulation rate and transferable embryos did not significantly change when 5 and 3 mg of FSH/kg body weight were injected, but they did notice a reduced ovarian response when 8 mg/kg body weight was used. In sheep, some studies found that a small decrease in the FSH dose had no effect. The ovarian response may not be significantly affected by a slight dosage reduction, according to these findings. A significant reduction, however, might result in a diminished ovarian response. Consequently, particularly in large-scale in vivo embryonic production, an ideal hormonal dose reduction can lower the cost of hormones without adversely influencing the ovarian response (Khan et al., 2023).

APPLICATIONS IN EMBRYO TRANSFER

Embryo transfer technology has just recently become widely used in animal breeding programs. The use of genetic engineering and associated new technologies will only grow (Table 2). These are some typical applications of embryo transfer technologies in the raising of cattle.

Genetic Improvement

Generally speaking, embryo transfer has been thought to produce genetic advancement more slowly than traditional artificial insemination, particularly when considering national herds. However, within-herd genetic gain is possible through shortened generation intervals and increased selection intensity, such as through the transfer of female offspring. As a result, the phrase MOET (multiple ovulation and embryo transfer) was created (Bekel et al., 2016). In a number of nations worldwide, nucleus herds are currently being established, with heifer offspring undergoing "Juvenile MOET" and male offspring being chosen for the upcoming AI bull generation. Genetic gains have been projected to be doubled in this method. The production of roughly six offspring per donor cow, however, has been calculated to increase the pace of response to genetic selection and the severity of selection for qualities like growth that can be evaluated in both sexes.

Artificial Insemination and Hormones

A major component of contemporary animal breeding systems is artificial insemination, or AI. It provides a significant blend of precise genetic control and economic advantages, making it a key method for improving animal populations' productivity and genetic makeup. It has also had a significant impact on the control of animal reproduction, allowing for the effective spread of desired features and the removal of geographical restrictions in animal breeding. AI isn't widely used in sheep, though, because of the problems with inconsistent and poor fertility outcomes. The efficiency of AI in sheep is influenced by a number of endogenous and exogenous factors that can differ greatly between individuals and breeds. In the area of ovine AI, great research has been done on the effects of exogenous elements such estrous induction, synchronization of semen collection techniques, and decisions about whether to use fresh, chilled, or frozen semen.

Endogenous factors contribute to the success of ovine AI initiatives. Ovine artificial intelligence is based on the careful selection of semen donors and recipients based on their genetic value. Animal genetic problems, fertility qualities, and breed characteristics all have a big influence. Furthermore, to maximize the success of ovine AI, other exogenous elements like diet and the current climate must be taken into consideration. In order to attain the best outcomes for such programs, a holistic strategy is necessary, as the interplay between endogenous and exogenous elements highlights the elaborate nature of ovine AI (Purdy et al., 2020).

Hormonal preparation for Timed Artificial Insemination (TAI)

But it's also critical to acknowledge how TAI protocols can be broadly classified into two pharmacological bases: (1) Ovsynch-type protocols that use gonadotropin-releasing hormone (GnRH) and (2) protocols that use progesterone treatment in addition to estradiol (E2) compounds (E2/P4 protocols). By either ovulating a dominant follicle following GnRH treatment or by blocking gonadotropins following treatment with E2 compounds plus P4 to stimulate follicle turnover in the current follicular wave, the strategy first aims to synchronize the emergence of a new follicular wave. Second, as the new preovulatory follicular wave develops, circulating P4 is kept at high levels. Third, utilizing prostaglandin F2α (PGF) to efficiently regress the corpus luteum (CL) reduces P4 and increases circulating E2 in the vicinity of TAI. Fourth, in accordance with the appropriate scheduling of TAI, a follicle of sufficient size and age is ovulated synchronously utilizing either GnRH or E2. Lastly, correctly functioning CL produced during the last ovulation maintains raised and steady circulating P4 (Consentini et al., 2021).

Embryo Transfer and Hormonal Support

ICSI was a standard practice for all fertilization processes. Two pronuclei were seen, indicating fertilization. In IVF Global® media (Life Global, Canada) supplemented with 10% synthetic serum substitute (SSS), embryos were cultivated until the day of transfer (Day 3). Prior to transfer, they were rated using the Veeck scoring system. Embryos classified as I or II were given to each woman. According to the Brazilian Federal Council of Medicine's (FCM) recommendations, the number of embryos transferred was defined. After oocyte retrieval, embryo transfers were carried out three days later. In order to observe the uterus through an acoustic window before to the ultrasound-guided embryo transfer, the patients were advised to have a full bladder. Every patient was put in the lithotomy position without being sedated or given an anesthetic. A 5 MHz probe was used for abdominal ultrasonography, and a Wallace Classic Soft Embryo Transfer Catheter was used for the embryo transfers (Scheffer et al., 2019)

TREATMENT OF REPRODUCTIVE DISORDERS

Gonadotropin-releasing hormone and exogenous luteinizing hormone are utilized to promote ovulation when insemination and delayed ovulation in relation to oestrus are thought to be the cause of repetitive breeding. Comparing repeat breeder cows treated with GnRH to untreated control animals, a review of many trials shows a favorable impact on conception rates. GnRH has also been used to activate the corpus luteum in cows during the luteal phase. Based on the idea that a primary cause of repetitive breeding is inadequate progesterone production that results in early embryonic mortality, this medication was developed (Liew et al., 2024). Additionally, progesterone medication has been utilized to support progesterone levels in early pregnancy in repeat breeder cows. According to studies, giving GnRH 12–14 days after giving birth may also shorten the time between parturition and conception and lower the risk of ovarian cysts. Many exogenous hormones have also been tried as a therapy to induce cyclicity in the anoestrous animal. It has been used to shorten the time between calving and conception or to accelerate puberty (Kirakosyan et al., 2021).

The older method of manually rupturing the ovaries' cystic structures has gradually been supplanted by hormonal treatment for cystic ovaries. In addition to avoiding unwanted side effects such as ovarian hemorrhage and adhesions that may occur after a manual rupture, pharmacological approaches of treatment appear to be more effective. Typically, the preferred preparations would be exogenous luteinizing hormone and, more importantly, gonadotrophin-releasing hormones that work on the pituitary gland to increase the release of endogenous LH. Occasionally, when the cystic formations are luteinized, prostaglandins are also employed. When GnRH has caused luteinization, prostaglandins can be administered to induce regression and shorten the time between GnRH treatment and oestrus. Cows with cystic ovaries can also have their oestrous cycles restored by administering gestagens (Bendarska-Czerwińska et al., 2023).

DRUGS USED IN HORMONAL TREATMENTS

Gonadotrophin-Releasing Hormone Analogues

It is used to trigger ovulation, cure cystic ovaries, and induce the secretion of LH and FSH.

Buserelin: Gonadotropin-releasing hormone (GnRH) synthetic analog buserelin [CAS: 68630–75-1 (C60H86N16O13)] is used to treat a number of hormone abnormalities. Compared to the natural hormone, it has a stronger effect on the pituitary's secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). In order to increase the chances of conception, it has been used to induce ovulation. Applying numerous doses, however, results in reversible pituitary desensitization. This leads to an orchidectomy environment that can be used to treat disorders that are sensitive to hormones. It has been demonstrated that buserelin is a viable option for treating a number of disorders linked to hormones. Pharmacokinetic studies of buserelin administered by subcutaneous (s.c.), intranasal (i.n.), or intravenous (i.v.) routes have been described in people and rats since the European Medicines Agency (EMA) approved it in 1995. These studies indicate that large doses impair follicular maturation and decrease estradiol synthesis and secretion. Data from the EMA after intravenous buserelin showed that it had a quick initial half-life of either 5 minutes for rats or 12 minutes for guinea pigs. Regardless of the buserelin administration method, half-life is eliminated in roughly 72 to 80 minutes. 15% or so of proteins bind. When intact buserelin builds up in the kidneys, liver, and pituitary gland, its metabolites are broken down and eliminated through the urine (Kong et al., 2022).

Deslorelin: An injectable GnRH agonist that inhibits the generation of sex hormones is deslorelin acetate, sometimes referred to as an LH-releasing hormone agonist. A subcutaneous implant with a maximum 6-month lifespan is offered. It is being used to treat ferrets with adrenal endocrinopathy, stabilize high-risk cattle pregnancies, and promote ovulation in mares. In contrast to other GnRH agonists that block FSH and LH, deslorelin is employed for its early action on the pituitary gland and the spike of LH secretion that goes along with it. One study in the European literature claimed that using deslorelin implants in guinea pigs did not result in a decrease in the size of ovarian cysts (Palm et al., 2012).

Prostaglandin F2a (PGF2a) Analogues

It is used to induce corpus luteum regression, or luteolysis, and to synchronize estrus. Dinoprost tromethamine, hormone prostaglandin F2 alpha (PGF2α), which is found naturally in mammals, is synthesized as dinoprosttromethamine. It primarily works by causing luteolysis, which is the corpus luteum's (CL) structural and functional regression. The hormone progesterone, which inhibits estrous and prolongs pregnancy, is secreted by the corpus luteum. The administration of dinoprost causes enzymatic and cellular alterations that lead to the breakdown of the CL by binding to certain prostaglandin receptors on luteal cells. Consequently, progesterone levels drop sharply, causing a new estrous cycle to begin. When infections or a retained placenta occur, this hormone can help discharge the contents of the uterus by stimulating smooth muscle contractions.

Dinoprost tromethamine is frequently used in veterinary reproductive care, particularly for pigs, sheep, goats, and cattle. One of its most popular uses is in estrus synchronization algorithms, which allow animals to enter estrus simultaneously by regressing the corpus luteum. Due to the ability to accurately schedule breeding, this is especially helpful in fixed-time artificial insemination (FTAI) procedures. Dinoprost dissolves the aberrant luteal tissue and restores regular cycles in cows with luteal ovarian cysts. Furthermore, it is crucial for causing parturition in cattle and pigs, particularly when labor needs to be controlled in the near future. Because it helps to empty the uterus, its uterine contractile qualities also make it useful for treating retained fetal membranes or metritis (Kebede et al., 2024).

Progesterone and Progestin Treatments

It is used to preserve pregnancy, reduce estrus, or synchronize the cycle. Altrenogest, A synthetic progestin called altrenogest is frequently used to control and suppress estrus in a variety of livestock species, especially in gilts (young female pigs) and mares (horses). It works by imitating the natural hormone progesterone, which suppresses the estrous cycle and prolongs pregnancy. Breeding timetables can be precisely controlled by temporarily suppressing reproductive cycles with oral Altrenogest administration. It is frequently used in mares to synchronize ovulation in preparation for artificial insemination or natural mating, as well as to reduce estrous activity in performance or competitive horses. Altrenogest is used to synchronize gilts' estrus, causing them to come into heat simultaneously after the drug is stopped. This increases the effectiveness of group breeding operations in pigs. After receiving medication for 14–18 days, gilts usually return to estrus in 4–7 days. In commercial pig production, this synchronization enables improved scheduling of farrowing and weaning. Altrenogest can also be given to help mares who are at risk of early embryonic loss because of low progesterone levels stay pregnant. Although correct withdrawal periods and handling precautions must be followed, particularly for pregnant women, its efficiency and convenience of oral administration make it a significant tool in reproductive treatment (Wang et al., 2018).

Follicle Stimulating Hormone (FSH)

It is utilized in embryo transfer superovulation procedures. Follotropin-V®, A veterinary preparation of follicle-stimulating hormone (FSH) made from pig pituitary extract is called Folltropin-V®. Its main purpose is to cause cattle to superovulate, especially valuable donor cows utilized in embryo transfer procedures. Cows normally only ovulate one dominant follicle every estrous cycle in the wild. But Folltropin-V promotes the growth and maturity of several ovarian follicles at once when given in a regulated, multiple-dose regimen.As a result, several oocytes can be collected and fertilized in vitro or in vivo. By transferring the resultant embryos to recipient females, the genetic impact of exceptional donor animals can be multiplied. To cause luteolysis and synchronize ovulation, folltropin-V is typically given over a period of 4–5 days, frequently in combination with prostaglandin. It is favored over previous FSH products because of its superior purity, steady efficacy, and fewer adverse effects. In cattle breeding operations, the effective application of Folltropin-V under veterinary supervision greatly increases the effectiveness of cutting-edge reproductive methods (Panyaboriban et al ., 2018).

Lutenizing Hormone (LH) or Hcg treatments

It is used to induce ovulation and simulate an LH surge. Human Chorionic Gonadotropin (hCG) is frequently used to stimulate ovulation in veterinary reproductive care, especially in small ruminants, cows, and mares. The ultimate maturation and release of the oocyte is triggered by hCG acting on mature ovarian follicles, simulating the natural LH surge that causes ovulation. In animals with irregular estrous cycles, artificial insemination, or timed breeding protocols, this is particularly helpful. Additionally, hCG is utilized to treat follicular cysts in cows by restoring normal cyclicity and luteinizing persistent follicles. When given to mares, hCG causes ovulation in a regular amount of time, usually 36 to 48 hours, which makes it perfect for synchronizing breeding. Furthermore, when progesterone levels are low, hCG can help early pregnancy by promoting corpus luteum function. Because of its adaptability, simplicity of use, and consistent ovulatory response, hCG is a vital component of hormonal reproductive therapies. To prevent decreased responsiveness brought on by antibody development, repeated use should be carefully controlled (Carvalho et al., 2018).

CONCLUSION

The complex process of animal reproduction is managed by the endocrine system. Hormones control ovulation, conception, pregnancy, parturition, and the estrous cycle. Important bodily processes that are controlled and synchronized by the endocrine system include growth and development, metabolism, sexual function and reproduction, sleep, and mood. The secretion of gonadotropins requires the pulsatile release of GnRH into the hypothalamic-hypophyseal portal veins. Luteinizing hormone (LH) is secreted by the anterior pituitary and is involved in male androgen synthesis and female ovulation. In animal reproduction, hormone therapy is widely used to increase fertility, regulate cycles, induce estrus, treat infertility, and support artificial breeding techniques. Better genotypes for milk production are having a negative effect on reproductive success in dairy cattle. In cattle farming systems, farm productivity, profitability, and sustainability are all significantly impacted by reproductive efficiency. Estrus synchronization is one of the advanced management strategies that could lower expenses and humanistic mistakes. It is common practice to use hormones to regulate the estrous cycle. In dairy farms, inadequate estrus detection efficiency is a major cause of poor reproductive performance, which is very costly for the cow industry. A naturally occurring hormone called PGF2α, which is one of the Estrous Synchronization protocols, promotes corpus luteum regression, or luteolysis, and lowers progesterone synthesis, which results in a return to estrus. An intravaginal insert impregnated with 1.38 grams of progesterone is used in a controlled internal drug-releasing (CIDR) device developed in the United States for nursing dairy calves. The introduction of continental cattle breeds, which were scarce at the time, marked the beginning of the commercial embryo transfer industry in North America in the early 1970s. Modern animal breeding methods heavily rely on artificial insemination, or AI.Exogenous luteinizing hormone (HCG) and gonadotrophin releasing hormone (GnRH) are used to induce ovulation when insemination and delayed ovulation in relation to oestrus are believed to be the cause of recurrent breeding.